Hedge Fund - Steadfast Capital Management
Valeant Pharmaceuticals Intl (VRX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2016 - Q1 (2016-03-31) | $0 | 0% | 0 | $73.95 |
| 2 | 2015 - Q4 (2015-12-31) | $88,657,000 | 1.69% | 872,178 | $112.55 |
| 3 | 2015 - Q3 (2015-09-30) | $310,419,000 | 6.21% | 1,740,214 | $233.19 |
| 4 | 2015 - Q2 (2015-06-30) | $188,145,000 | 2.78% | 846,927 | $221.70 |
| 5 | 2015 - Q1 (2015-03-31) | $182,517,000 | 2.54% | 918,924 | $177.40 |
| 6 | 2014 - Q3 (2014-09-30) | $0 | 0% | 0 | $119.20 |
| 7 | 2014 - Q2 (2014-06-30) | $92,543,000 | 1.5% | 733,772 | $127.57 |
| 8 | 2014 - Q1 (2014-03-31) | $227,466,000 | 4.84% | 1,725,450 | $136.73 |
| 9 | 2013 - Q4 (2013-12-31) | $310,278,000 | 7.1% | 2,642,912 | $109.57 |
| 10 | 2013 - Q3 (2013-09-30) | $230,369,000 | 6.01% | 2,208,083 | $97.42 |
| 11 | 2013 - Q2 (2013-06-30) | $175,023,000 | 5.11% | 2,033,263 | $78.80 |
| 12 | 2013 - Q1 (2013-03-31) | $66,377,000 | 1.75% | 884,786 | $67.20 |
| 13 | 2012 - Q4 (2012-12-31) | $93,894,000 | 2.5% | 1,570,927 | $56.68 |
| 14 | 2012 - Q3 (2012-09-30) | $121,258,000 | 3.68% | 2,193,916 | $51.17 |
| 15 | 2012 - Q1 (2012-03-31) | $155,305,000 | 4.54% | 2,892,628 | $50.92 |
| 16 | 2011 - Q4 (2011-12-31) | $204,581,000 | 5.74% | 4,381,690 | $41.70 |
| 17 | 2011 - Q3 (2011-09-30) | $156,387,000 | 4.92% | 4,213,011 | $45.53 |
| 18 | 2011 - Q2 (2011-06-30) | $231,072,000 | 8.51% | 4,447,112 | $51.68 |
| 19 | 2011 - Q1 (2011-03-31) | $200,784,000 | 7.51% | 4,030,993 | $39.01 |
The displayed share prices are average quarterly stock market prices.